Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-570159
Filing Date
2016-04-29
Accepted
2016-04-29 17:29:02
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d187119d10ka.htm 10-K/A 291151
2 EX-31.1 d187119dex311.htm EX-31.1 2247
3 EX-31.2 d187119dex312.htm EX-31.2 2263
4 GRAPHIC g187119fspg01.jpg GRAPHIC 10520
5 GRAPHIC g187119tocpg01.jpg GRAPHIC 14607
  Complete submission text file 0001193125-16-570159.txt   331877
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33958 | Film No.: 161608607
SIC: 2834 Pharmaceutical Preparations